|
|
||||||||
979.11 |
Asthma, Allergy and Lung Biology, Kings College London, 2nd floor Thomas Guy House, Guys Campus, London, SE1 9RT, United Kingdom
ABSTRACT
Vasodilators that increase cGMP reduce Ca2+ sensitivity as well as Ca2+, and may inhibit the RhoA/Rho kinase pathway. We examined cGMP-mediated Ca2+ desensitisation using 8-Br-cGMP, in rat
-toxin permeabilized intrapulmonary arteries (IPA). In IPA contracted by raising Ca2+, 8-Br-cGMP relaxed IPA with an EC50 of ~25nM. Surprisingly, the Rho kinase inhibitor Y-27632 (10µM) had no significant effect. Consistent with this, 100nM 8-Br-cGMP caused a significant shift in the Ca2+ response curve (EC50 Control: 157 ± 23 nM; 8-Br-cGMP: 252 ± 47 nM); although Y-27632 also increased the EC50 (204 ± 26 nM), in its presence 8-Br-cGMP still caused a further increase (306 ± 45nM). Similar results were obtained with PGF2
, which activates Rho kinase. The effects of 8-Br-cGMP were not inhibited by KT5823, a PKG inhibitor, but were by H89, a PKA inhibitor. Similarly, Rp-8-Br-cAMP (25 µM) depressed 8-Br-cGMP-mediated relaxation at pCa 6.8 from 76.9 ± 2.5% to 43.1 ± 4.5%. 8-Br-cGMP had a greater effect on MLC phosphorylation than on that of MYPT1. This suggests 8-Br-cGMP reduces Ca2+ sensitivity in IPA via PKA, possibly involving its target teleokin which affects myosin phosphatase.
Supported by MRC and Wellcome Trust.
| ||||||||||||||||||||||||||||||||||||||||||||